Changes in prodynorphin gene expression and neuronal morphology in the hypothalamus of postmenopausal women

Journal of Neuroendocrinology

Volumn 20, Issue 12, 2008, Pages 1376-1381

  Rometo, A M ^a   Rance, Naomi E ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Dynorphin; GnRH; Human; Kisspeptin; Menopause; Neurokinin B; Oestrogen; Oestrogen receptor

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PRODYNORPHIN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; CELL COUNT; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; IN SITU HYBRIDIZATION; INFUNDIBULUM; ISOTOPE LABELING; MICROSCOPY; OVARY INSUFFICIENCY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADOLESCENT; ADULT; AGED; ANIMALS; AUTORADIOGRAPHY; CELL SHAPE; ENKEPHALINS; FEMALE; GENE EXPRESSION; HUMANS; HYPOTHALAMUS; MIDDLE AGED; NEURONS; POSTMENOPAUSE; PROTEIN PRECURSORS; YOUNG ADULT;

EID: 56649096022     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2008.01796.x     Document Type: Article

References (45)

1. Block E. Quantitative morphological investigations of the follicular system in women; variations at different ages. Acta Anat 1952; 14: 108-123.
2. Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA. A new model of reproductive aging: The decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod 2008; 23: 699-708.
3. Rance NE. Menopause and the human hypothalamus: Evidence for a role of kisspeptin/neurokinin B neurons in the regulation of estrogen negative feedback. Peptides 2008 (in press).
4. Rance NE, McMullen NT, Smialek JE, Price DL, Young WS III. Postmenopausal hypertrophy of neurons expressing the estrogen receptor gene in the human hypothalamus. J Clin Endocrinol Metab 1990; 71: 79-85.
5. Rance NE, Young WS III. Hypertrophy and increased gene expression of neurons containing neurokinin-B and substance-P messenger ribonucleic acids in the hypothalami of postmenopausal women. Endocrinology 1991; 128: 2239-2247.
6. Rometo AM, Krajewski SJ, Voytko ML, Rance NE. Hypertrophy and increased kisspeptin gene expression in the hypothalamic infundibular nucleus of postmenopausal women and ovariectomized monkeys. J Clin Endocrinol Metab 2007; 92: 2744-2750.
7. Sandoval-Guzmán T, Stalcup ST, Krajewski SJ, Voytko ML, Rance NE. Effects of ovariectomy on the neuroendocrine axes regulating reproduction and energy balance in young cynomolgus macaques. J Neuroendocrinol 2004; 16: 146-153.
8. Goubillon M-L, Forsdike RA, Robinson JE, Ciofi P, Caraty A, Herbison AE. Identification of neurokinin B-expressing neurons as an highly estrogen-receptive, sexually dimorphic cell group in the ovine arcuate nucleus. Endocrinology 2000; 141: 4218-4225.
9. Kauffman AS, Clifton DK, Steiner RA. Emerging ideas about kisspeptin - GPR54 signaling in the neuroendocrine regulation of reproduction. Trends Neurosci 2007; 30: 504-511.
10. Roa J, Aguilar E, Dieguez C, Pinilla L, Tena-Sempere M. New frontiers in kisspeptin/GPR54 physiology as fundamental gatekeepers of reproductive function. Front Neuroendocrinol 2008; 29: 48-69.
11. Yen SSC, Quigley ME, Reid RL, Ropert JF, Cetel NS. Neuroendocrinology of opioid peptides and their role in the control of gonadotropin and prolactin secretion. Am J Obstet Gynecol 1985; 152: 485-493.
12. Gindoff PR, Ferin M. Brain opioid peptides and menstrual cyclicity. Semin Reprod Endocrin 1987; 5: 125-133.
13. Goodman RL, Coolen LM, Anderson GM, Hardy SL, Valent M, Connors JM, Fitzgerald ME, Lehman MN. Evidence that dynorphin plays a major role in mediating progesterone negative feedback on gonadotropin-releasing hormone neurons in sheep. Endocrinology 2004; 145: 2959-2967.
14. Foradori CD, Coolen LM, Fitzgerald ME, Skinner DC, Goodman RL, Lehman MN. Colocalization of progesterone receptors in parvicellular dynorphin neurons of the ovine preoptic area and hypothalamus. Endocrinology 2002; 143: 4366-4374.
15. Foradori CD, Amstalden M, Goodman RL, Lehman MN. Colocalisation of dynorphin A and neurokinin B immunoreactivity in the arcuate nucleus and median eminence of the sheep. J Neuroendocrinol 2006; 18: 534-541.
16. Burke MC, Letts PA, Krajewski SJ, Rance NE. Coexpression of dynorphin and neurokinin B immunoreactivity in the rat hypothalamus: Morphologic evidence of interrelated function within the arcuate nucleus. J Comp Neurol 2006; 498: 712-726.
17. Ciofi P, Leroy D, Tramu G. Sexual dimorphism in the organization of the rat hypothalamic infundibular area. Neuroscience 2006; 141: 1731-1745.
18. Goodman RL, Lehman MN, Smith JT, Coolen LM, de Oliveira CVR, Jafarzadehshirazi MR, Pereira A, Iqbal J, Caraty A, Ciofi P, Clarke IJ. Kisspeptin neurons in the arcuate nucleus of the ewe express both dynorphin A and neurokinin B. Endocrinology 2007; 148: 5752-5760.
19. Foradori CD, Goodman RL, Adams VL, Valent M, Lehman MN. Progesterone increases dynorphin A concentrations in cerebrospinal fluid and preprodynorphin messenger ribonucleic acid levels in a subset of dynorphin neurons in the sheep. Endocrinology 2005; 146: 1835-1842.
20. Civelli O, Douglass J, Goldstein A, Herbert E. Sequence and expression of the rat prodynorphin gene. Proc Natl Acad Sci USA 1985; 82: 4291-4295.
21. Horikawa S, Takai T, Toyosato M, Takahashi H, Noda M, Kakidani H, Kubo T, Hirose T, Inayama S, Hayashida H, Miyata T, Numa S. Isolation and structural organization of the human preproenkephalin B gene. Nature 1983; 306: 611-614.
22. Sukhov RR, Walker LC, Rance NE, Price DL, Young WS III. Opioid precursor gene expression in the human hypothalamus. J Comp Neurol 1995; 353: 604-622.
23. Nauta WJH, Haymaker W. Hypothalamic nuclei and fiber connections. In: Haymaker W, Anderson E, Nauta WJH, eds. The Hypothalamus. Springfield, IL: Charles C. Thomas, 1969: 136-209.
24. Sheehan HL. Variations in the subventricular nucleus. J Pathol Bacteriol 1967; 94: 409-416.
25. Abel TW, Rance NE. Stereologic study of the hypothalamic infundibular nucleus in young and older women. J Comp Neurol 2000; 424: 679-688.
26. Abe J, Okamura H, Kitamura T, Ibata Y, Minamino N, Matsuo H, Paull WK. Immunocytochemical demonstration of dynorphin(PH-8P)-like immunoreactive elements in the human hypothalamus. J Comp Neurol 1988; 276: 508-513.
27. Foradori CD, Goodman RL, Lehman MN. Distribution of preprodynorphin mRNA and dynorphin - a immunoreactivity in the sheep preoptic area and hypothalamus. Neuroscience 2005; 130: 409-418.
28. Leadem CA, Kalra SP. Effects of endogenous opioid peptides and opiates on luteinizing hormone and prolactin secretion in ovariectomized rats. Neuroendocrinology 1985; 41: 342-352.
29. Smith AP, Lee NM. Pharmacology of dynorphin. Annu Rev Pharmacol Toxicol 1988; 28: 123-140.
30. Smith MJ, Gallo RV. The effect of blockade of kappa-opioid receptors in the medial preoptic area on the luteinizing hormone surge in the proestrous rat. Brain Res 1997; 768: 111-119.
31. Naqvi T, Haq W, Mathur KB. Structure-activity relationship studies of dynorphin A and related peptides. Peptides 1998; 19: 1277-1292.
32. Zhang Q, Gallo RV. Presence of kappa-opioid tone at the onset of the ovulatory luteinizing hormone surge in the proestrous rat. Brain Res 2003; 980: 135-139.
33. Dufourny L, Skinner DC. Progesterone receptor, estrogen receptor alpha, and the type II glucocorticoid receptor are coexpressed in the same neurons of the ovine preoptic area and arcuate nucleus: A triple immunolabeling study. Biol Reprod 2002; 67: 1605-1612.
34. Quigley ME, Yen SSC. The role of endogenous opiates in LH secretion during the menstrual cycle. J Clin Endocrinol Metab 1980; 51: 179-181.
35. Ropert JF, Quigley ME, Yen SSC. Endogenous opiates modulate pulsatile luteinizing hormone release in humans. J Clin Endocrinol Metab 1981; 52: 583-585.
36. Shoupe D, Montz FJ, Lobo RA. The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women. J Clin Endocrinol Metab 1985; 60: 178-183.
37. Melis GB, Paoletti AM, Gambacciani M, Mais V, Fioretti P. Evidence that estrogens inhibit LH secretion through opioids in postmenopausal women using naloxone. Neuroendocrinology 1984; 39: 60-63.
38. Casper RF, Alapin-Rubillovitz S. Progestins increase endogenous opioid peptide activity in postmenopausal women. J Clin Endocrinol Metab 1985; 60: 34-36.
39. Dawood MY, Khan-Dawood FS, Ramos J. The effect of estrogen-progestin treatment on opioid control of gonadotropin and prolactin secretion in postmenopausal women. Am J Obstet Gynecol 1986; 155: 1246-1251.
40. Knobil E. The neuroendocrine control of the menstrual cycle. Recent Prog Horm Res 1980; 36: 53-88.
41. Yakimova KS, Sann H, Pierau FK. Effects of kappa and delta opioid agonists on activity and thermosensitivity of rat hypothalamic neurons. Brain Res 1998; 786: 133-142.
42. Xin L, Geller EB, Adler MW. Body temperature and analgesic effects of selective mu and kappa opioid receptor agonists microdialyzed into rat brain. J Pharmacol Exp Ther 1997; 281: 499-507.
43. Spencer RL, Hruby VJ, Burks TF. Alteration of thermoregulatory set point with opioid agonists. J Pharmacol Exp Ther 1990; 252: 696-705.
44. Simpkins JW, Katovich MJ, Song I-C. Similarities between morphine withdrawal in the rat and the menopausal hot flush. Life Sci 1983; 32: 1957-1966.
45. Merchenthaler I, Funkhouser JM, Carver JM, Lundeen SG, Ghosh K, Winneker RC. The effect of estrogens and antiestrogens in a rat model for hot flush. Maturitas 1998; 30: 307-316.